FdaApplication
ANDA 217264
Identifiers
- fda_app_no: ANDA217264
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMAZONE |
| application_type | ANDA |
| approval_date | 2023-09-29 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ESOMEPRAZOLE MAGNESIUM | ESOMEPRAZOLE MAGNESIUM | EQ 20MG BASE | CAPSULE, DELAYED RELEASE;ORAL |
1 product